Carl Peck | GenomeWeb

Carl Peck


Population-based pharmacokinetic simulation firm Simcyp has appointed Carl Peck to its scientific advisory board. Peck is the founding director of the Center for Drug Development Science at the University of California, San Francisco; a former director of the US Food and Drug Administration’s Center for Drug Evaluation and Research, and a former assistant surgeon general.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.